- Report
- October 2024
- 183 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- April 2025
- 363 Pages
Global
From €5225EUR$5,450USD£4,366GBP
- Report
- August 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- August 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- July 2024
- 100 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- February 2025
- 181 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2025
- 180 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- October 2022
- 119 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- December 2023
- 140 Pages
Global
From €4266EUR$4,450USD£3,565GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Report
- February 2023
- 198 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Report
- January 2024
- 200 Pages
Global
From €3978EUR$4,150USD£3,324GBP
- Report
- February 2024
- 120 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- April 2023
- 122 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- June 2022
- 120 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- October 2023
- 181 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- September 2022
- 149 Pages
Global
From €3451EUR$3,600USD£2,884GBP
- Report
- January 2024
- 310 Pages
Global
€4789EUR$4,995USD£4,001GBP
- Report
- September 2022
- 109 Pages
Global
From €1917EUR$2,000USD£1,602GBP

The Orexin Receptor market is a subset of the Central Nervous System Drugs market. It is composed of drugs that target the Orexin Receptor, a protein found in the brain that is involved in the regulation of sleep and wakefulness. Orexin Receptor agonists are used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. Orexin Receptor antagonists are used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep.
The Orexin Receptor market is a rapidly growing segment of the Central Nervous System Drugs market. It is expected to experience strong growth in the coming years due to the increasing prevalence of sleep disorders and the development of new drugs targeting the Orexin Receptor.
Some companies in the Orexin Receptor market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and Takeda. Show Less Read more